Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
77 participants
OBSERVATIONAL
2009-04-30
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective:To measure chest wall dynamics, derived from sensors placed on the chest and abdomen.
Methods: The system comprises of patches attached to the chest wall and upper abdomen that include mechanical sensors that measure the mechanics of lung inflation and deflation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Monitoring of the Lungs Ventilation Dynamics During Mechanical Ventilation
NCT00702169
Mechanical Ventilation in Internal Medicine Elderly Patients - Choosing Wisely
NCT02379884
Retrospective Review of Mechanically Ventilated Patients Using a Continuous Data Collection System.
NCT02184208
Comparative Study of Non-Invasive Mask Ventilation vs Cuirass Ventilation in Patients With Acute Respiratory Failure.
NCT00331656
Diaphragm Injury and Dysfunction During Mechanical Ventilation
NCT03108118
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Neonates especially need tight and sensitive monitoring of lung ventilation, because of the high prevalence of lung disease and need for ventilatory support in this population.
Methods:
The system comprises of patches attached to the chest wall and to the epigastrium. The patches include sensors that measure the mechanics of the lung inflation and deflation.
Study protocol
* Following parental informed consent, three patches will be placed on both sides of the chest and over the epigastric area in infants that require tight respiratory monitoring.
* The patches will be placed just beside the ECG patches.
* The placement of the patches will be performed by a physician.
* The monitoring can be preformed as long as the baby needs a tight respiratory monitoring. The patches will be replaced according to routine replacement policy of patches in the neonatal intensive care units, and at the regular time defined by the attending staff, and no longer than 24 hours. At the end of the data acquisition, the patches will be removed.
* No additional intervention is required.
* The patient will be inspected by the supervising physician involve in the research.
* It will not provide any data that may alter the treatment and will not interfere or influence the other monitoring devices that are used to evaluate the clinical status of the patient.
* The other parameters that are regularly monitored, that are displayed on the bedside monitor and respirator will be recorded by the research assistant. The ventilated baby will be identified by a study number. There will be a separate database for the measurements and the demographic and clinical data. There will be no disclosure of the patient's identity along with the data analysis and publication of the results or communication to authorities or other medical practitioners.
Equipment safety:
The system is safe for the use in human subjects. The whole system is approved for safety according to the acquired standard ICE-60601
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Newborns needing respiratory monitoring
Premature and term newborn infants (male/female)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parents that understand and read Hebrew or Russian or Arabic.
Exclusion Criteria
* Premature babies under 700 grams.
* Prematurity below 26 weeks gestation.
* Severe edematous babies (Hydrops fetalis).
* Severe Hypoxic Ischemic Encephalopathy, initial brain injury or severe intracranial bleeding.
* Skin reactions to the adhesive patches.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Carmel Medical Center
OTHER
Bnai Zion Medical Center
OTHER_GOV
Rambam Health Care Campus
OTHER
Pneumedicare Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dan Waisman, MD
Role: STUDY_DIRECTOR
Department of Neonatology Carmel Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bnai Zion Medical Center
Haifa, , Israel
Department of Neonatology, Carmel Medical Center
Haifa, , Israel
Rambam Health Care Campus
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NEO-01/2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.